AI assistant
NEOGENOMICS INC — Director's Dealing 2017
Dec 14, 2017
32227_dirs_2017-12-14_b8254073-5dc2-4cbd-a678-f690a375f22c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-06-27
Reporting Person: JONES STEVEN C (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-14 | Common Stock | G | 20000 | $9.06 | Disposed | 226251 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3150000 | Indirect |
| Common Stock | 50476 | Indirect |
| Common Stock | 52157 | Indirect |
| Common Stock | 190000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.78 | 2020-05-04 | Common Stock (225000) | 225000 | Direct |
| Stock Option (Right to Buy) | $7.15 | 2021-04-20 | Common Stock (100000) | 100000 | Direct |
| Stock Option | $7.27 | 2022-05-25 | Common Stock (10000) | 10000 | Direct |
| Restricted Stock | $0.00 | Common Stock (8667) | 8667 | Direct |
Footnotes
F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
F2: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
F5: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F6: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018.
F7: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.